2025
|
P/S
|
Veterinary pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central n... |
|
P/S
|
Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ... |
|
P/S
|
Providing medical information in the field of heart disease; Providing information in the field o... |
|
P/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
P/S
|
Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brai... |
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
P/S
|
Pharmaceutical preparations and substances; sanitary preparations for medical purposes. |
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
P/S
|
Medical information services, namely, providing medical information on the topic of cancer; Onlin... |
|
Invention
|
Nitrogen-linked benzisoxazole sulfonamide derivatives.
The present invention relates to compound... |
|
Invention
|
Glp-1 receptor agonists and uses thereof.
Provided herein are 6-carboxylic acids of benzimidazol... |
|
Invention
|
3,4-dihydro-2,7-naphthyridine-1,6(2h,7h)-diones as mek inhibitors.
The invention relates to a me... |
|
Invention
|
Compounds for the treatment of braf-associated diseases and disorders.
Provided herein is a comp... |
|
P/S
|
Medical information services, namely, providing information related to vaccines for C Difficile i... |
|
P/S
|
Medical syringes; Medical apparatus, namely, infusion and injection devices for administering drugs |
|
Invention
|
Vial for containing a pharmaceutical product and filling system suitable for filling such vials i... |
|
Invention
|
Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof. Described her... |
|
Invention
|
Vaccines against respiratory diseases. The present disclosure relates to hMPV F protein mutants, ... |
|
Invention
|
Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compou... |
|
Invention
|
Benzodiazepine pyrazolo carboxamides as n-protein inhibitors.
The invention relates to benzodiaz... |
|
Invention
|
Benzodiazepine pyrazolo carboxamides as n-protein inhibitors. The invention relates to benzodiaze... |
|
Invention
|
Health information nework wellness platform. A system and method for providing a user with inform... |
|
Invention
|
Digital migraine management system. Systems and methods for assisting users in managing migraines... |
2024
|
Invention
|
Crystalline forms of a muscarinic m4 receptor modulator and methods of treating diseases. Crystal... |
|
Invention
|
Novel method of preparing ervogastat. The present invention relates to a novel method of preparin... |
|
Invention
|
Solid forms of 6-[4-[[3-(difluoromethoxy)-2-pyridinyl]oxy]-2-methylphenyl]-1,5-dimethyl-2,4(1h, 3... |
|
Invention
|
Crystalline form of 2-methoxy-n-{4-methoxy-6-[(1h-pyrazol-1-yl)methyl]-1,2-benzoxazol-3-yl}benzen... |
|
Invention
|
Methods and vaccine compositions for lyme disease. Described are compositions and methods for pre... |
|
Invention
|
Solid forms of a gabaa receptor modulator and methods of its use. Solid crystalline forms of GABA... |
|
Invention
|
Inhibitors.
Described herein are novel compounds in an isolated or crystalline form, pharmaceuti... |
|
Invention
|
Nitrogen-containing heteroaryl compounds for the treatment of chronic diseases. The disclosure re... |
|
Invention
|
Improved methods for producing bacterial capsular saccharide glycoconjugates. The disclosure prov... |
|
Invention
|
Acetyl coa-carboxylase (acc) inhibitors. 12344 is H or OH; and, wherein the dashed line may be pr... |
|
Invention
|
Lipid compounds and uses thereof. Compounds are provided having the following structure: (I) or a... |
|
Invention
|
Lipid compounds and uses thereof. Compounds are provided having the following structure (I) or a ... |
|
Invention
|
Rna molecules. The present disclosure relates to RNA molecules encoding a respiratory syncytial v... |
|
Invention
|
Rna molecules. The present disclosure relates to RNA molecules encoding a Neisseria meningitidis ... |
|
Invention
|
Biphenyl and phenylpyridine compounds as inhibitors of kat2a and/or kat2b. The invention relates ... |
|
Invention
|
Biphenyl and phenylpyridine compounds.
The invention relates to compounds of Formula (1):
The ... |
|
Invention
|
Therapy for the treatment of multiple myeloma. Provided herein are methods of treating and/or man... |
|
Invention
|
Combination therapies for treatment of breast cancer. Provided are a combination therapy comprisi... |
|
Invention
|
Benzodiazepine compounds as n-protein inhibitors. The present disclosure relates to benzodiazepin... |
|
Invention
|
Combination therapies for treatment of breast cancer.
Provided are a combination therapy compris... |
|
Invention
|
Novel antibodies and antibody conjugates for the treatment of metabolic disorders.
Disclosed her... |
|
Invention
|
Synthesis of 1,5-anhydro-3-({5-chloro-4-[4-fluoro-2-(2-hydroxypropan-2-yl)-1-(propan-2-yl)-1h-ben... |
|
Invention
|
Immunogenic compositions against influenza. The disclosure relates to compositions and methods fo... |
|
Invention
|
Lfa3 variants and compositions and uses thereof.
The invention provides LFA3 polypeptide molecul... |
|
Invention
|
Sulfonyl amide derivatives for the treatment of abnormal cell growth.
The present invention rela... |
2023
|
Invention
|
Process and intermediates useful for preparing nirmatrelvir.
The present invention is directed t... |
|
Invention
|
Methods for producing nucleic acids.
Described are methods for producing RNA molecules in an in ... |
|
Invention
|
Methods for producing an adjuvant.
This invention provides methods for producing homogeneous and... |
|
Invention
|
Computerized decision support tool and medical device for respiratory condition monitoring and ca... |
|
Invention
|
Methods for incorporating azido groups in bacterial capsular polysaccharides.
The present invent... |
|
Invention
|
Coronavirus antigen variants.
The present disclosure provides isolated immunogenic polypeptides ... |
2022
|
Invention
|
Digital medicine companion for cdk inhibitor medications for cancer patients.
The present disclo... |
|
Invention
|
Enhancement of cd47 blockade with taxanes for cd47+ cancer therapy.
The invention provides combi... |
|
Invention
|
Immunogenic lnp compositions and methods thereof.
The invention relates to compositions and meth... |